SYMCLIQ Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for SYMCLIQ with the United States Patent and Trademark Office. The USPTO has given the SYMCLIQ trademark a serial number of 86897398. The federal status of this trademark filing is REGISTERED as of Tuesday, July 7, 2020. This trademark is owned by Sun Pharma Global FZE. The SYMCLIQ trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceuticals; Medical apparatus for introducing pharmaceutical preparations into the human body; Syringes for medical purposes and for injections; Injection syringes
symcliq

General Information

Serial Number86897398
Word MarkSYMCLIQ
Filing DateThursday, February 4, 2016
Status700 - REGISTERED
Status DateTuesday, July 7, 2020
Registration Number6093344
Registration DateTuesday, July 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Translation of Words in MarkThe wording "SYMCLIQ" has no meaning in a foreign language.
Goods and ServicesInjection device for pharmaceuticals; Medical apparatus for introducing pharmaceutical preparations into the human body; Syringes for medical purposes and for injections; Injection syringes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUN PHARMACEUTICAL INDUSTRIES LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressVADODARA, GUJARAT 390012
IN
Party NameSun Pharma Global FZE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDubai
AE

Trademark Events

Event DateEvent Description
Tuesday, February 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 8, 2016NEW APPLICATION ENTERED
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Monday, May 16, 2016SUSPENSION LETTER WRITTEN
Monday, May 16, 2016LETTER OF SUSPENSION E-MAILED
Monday, May 16, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 18, 2016ASSIGNED TO LIE
Monday, November 28, 2016SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, December 2, 2016SUSPENSION INQUIRY WRITTEN
Friday, December 2, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, December 2, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, January 9, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 18, 2017SUSPENSION LETTER WRITTEN
Wednesday, January 18, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, January 18, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 20, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, July 27, 2017SUSPENSION INQUIRY WRITTEN
Thursday, July 27, 2017INQUIRY TO SUSPENSION E-MAILED
Thursday, July 27, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 24, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2018SUSPENSION LETTER WRITTEN
Wednesday, January 31, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, January 31, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 1, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, August 8, 2018SUSPENSION INQUIRY WRITTEN
Wednesday, August 8, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 8, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, February 4, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 7, 2019SUSPENSION LETTER WRITTEN
Thursday, February 7, 2019LETTER OF SUSPENSION E-MAILED
Thursday, February 7, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 8, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, August 8, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 8, 2019SUSPENSION INQUIRY WRITTEN
Thursday, August 8, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 19, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 19, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 25, 2020PETITION TO REVIVE-GRANTED
Tuesday, February 25, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 26, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, February 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 27, 2020NON-FINAL ACTION WRITTEN
Thursday, February 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 27, 2020NON-FINAL ACTION E-MAILED
Monday, March 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 7, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

symcliq injection syringes medical injections body purposes human pharmaceutical device pharmaceuticals